Pricing Log in Create free account

Molecular Partners AG Sponsored ADR (MOLN) vs Yarrow Bioscience, Inc (YARW)

Molecular Partners AG Sponsored ADR and Yarrow Bioscience, Inc are both Biotechnology companies. Yarrow Bioscience, Inc is the larger, with a market value of $147.2M against $119.2M — 1.2× the size. Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −28.0%. Molecular Partners AG Sponsored ADR has the higher net margin (0.00% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Molecular Partners AG Sponsored ADR leads on 8 and Yarrow Bioscience, Inc on 8.

Valuation

Metric MOLN YARW Biotechnology median
P/E n/m n/m 10.60
P/S 21.86 27.77 9.40
P/B 1.98 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.32 118.48 9.02
Earnings yield (52.05%) (138.76%) (32.88%)
Free cash flow yield (45.19%) (127.91%) (23.13%)

Profitability

Metric MOLN YARW Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (71.08%) (61.40%) (51.96%)
Return on assets (58.83%) (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MOLN YARW Biotechnology median
Revenue growth (TTM) (27.99%) 1.26% 6.76%
EPS growth (last fiscal year) (9.94%) 32.26% 29.88%
Revenue growth, 5-year CAGR (23.12%) (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOLN YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.46 15.26 4.97
Net debt to EBITDA 1.66 0.95 1.01

Dividend

Metric MOLN YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric MOLN YARW Biotechnology median
Market cap 119.24m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack